• Company
• Verquvo busy securing prescriptions in KOR with reimb
• by Eo, Yun-Ho Aug 29, 2023 05:28am

• Policy
• MOHW-Roche have difficulty discussing resupply of Madopar
• by Lee, Jeong-Hwan Aug 28, 2023 05:21am

• Company
• Price negotiation period for Spinraza and Evrysdi extended
• by Eo, Yun-Ho Aug 28, 2023 05:21am

• Company
• Trulicity's share reaches 99.8%
• by Kim, Jin-Gu Aug 28, 2023 05:21am

• Company
• Discussion on expanding coverage for Leclaza begins
• by Eo, Yun-Ho Aug 28, 2023 05:21am

• Company
• New drug Shingrix leads shingles vaccine mkt
• by Chon, Seung-Hyun Aug 28, 2023 05:21am

• Company
• Hanmi Pharm starts P1T on its next-gen immuno-oncology drug
• by Chon, Seung-Hyun Aug 25, 2023 06:06am

• Policy
• Are there any countermeasures against Rx of hair loss pills?
• by Lee, Jeong-Hwan Aug 25, 2023 06:06am

• Policy
• Bayer completes pricing negotiations for Jivi Inj in KOR
• by Lee, Tak-Sun Aug 25, 2023 06:06am

• Policy
• Reduction in the scope of platform regulation & re-examinati
• by Lee, Jeong-Hwan Aug 25, 2023 06:06am